Larvol Delta - Study-of-BND22-Administered-Alone-and-in-Combination-With-Other-Therapeutics-in-Participants-With-Advanced-Solid-Tumors

Erbitux (cetuximab) - Eli Lilly, EMD Serono

BND-22 - Biond Biologics, Sanofi

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT04717375

Oct 1, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next